Advertisement

Sleep and Breathing

, Volume 22, Issue 3, pp 853–863 | Cite as

dl-Propargylglycine protects against myocardial injury induced by chronic intermittent hypoxia through inhibition of endoplasmic reticulum stress

  • Xiufang Zhou
  • Si Tang
  • Ke Hu
  • Zhan Zhang
  • Pei Liu
  • Yuchuan Luo
  • Jing Kang
  • Lifang Xu
Hypoxia • Original Article

Abstract

Background

Chronic intermittent hypoxia (CIH), an important basis of the pathogenesis of organ damage induced by obstructive sleep apnea syndrome (OSAS), is associated with myocardial injury, such as left ventricular dysfunction, apoptosis, and oxidative stress. Endogenous hydrogen sulfide (H2S) plays an important role in maintaining cardiovascular functions. Many studies have demonstrated that exogenous H2S has protective effects against myocardial injury induced by various cardiovascular diseases, and inhibiting the generation of endogenous H2S has opposite effects. However, the effect of dl-propargylglycine (PAG), an effective inhibitor of cystathionine γ-lyase (CSE)-synthesized H2S, on the regulation myocardial injury remains controversial.

Purpose

The present study was aimed to explore the influence of PAG on myocardial injury induced in rats by CIH.

Methods

Sprague-Dawley rats were randomly divided into a normal control (NC) group, a CIH group, a NC + PAG group, and a CIH + PAG group. After establishing the CIH model in rats, blood pressure, left ventricular function, oxidative stress, apoptosis, and the level of endoplasmic reticulum (ER) stress were detected.

Results

In NC rats, PAG had no effect on blood pressure, but induced myocardial dysfunction and up-regulated oxidative stress and apoptosis of the myocardium. In the CIH + PAG group, pretreatment with PAG significantly reduced blood pressure and improved the left ventricular ejection fraction (LVEF) and the left ventricular fractional shortening (LVFS) compared to the CIH group. Significantly lower levels of oxidative stress, apoptosis, and the ER stress were detected in the CIH + PAG group than in the CIH group.

Conclusion

These results suggest that PAG can protect the myocardium against CIH-induced injury through inhibition of endoplasmic reticulum stress.

Keywords

Chronic intermittent hypoxia dl-Propargylglycine Myocardial injury Apoptosis Oxidative stress Endoplasmic reticulum stress 

Notes

Acknowledgements

We appreciate the assistance of Dr. Jing Feng and Prof. Baoyuan Chen (Respiratory Department, Tianjin Medical University General Hospital, China) for their support with the intermittent hypoxia chamber and the gas control delivery system used in this study to establish the CIH rat model.

Funding

The National Natural Science Foundation of China provided financial support in the form of national natural science funding (Nos. 81070065 and 81370181). The sponsor had no role in the design or conduct of this research.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, Barbe F, Vicente E, Wei Y, Nieto FJ, Jelic S (2012) Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 307(20):2169–2176.  https://doi.org/10.1001/jama.2012.3418 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235.  https://doi.org/10.1056/nejm199304293281704 CrossRefPubMedGoogle Scholar
  3. 3.
    Turoff A, Thiem U, Fox H, Spiesshofer J, Bitter T, Tamisier R, Punjabi NM, Horstkotte D, Oldenburg O (2017) Sleep duration and quality in heart failure patients. Sleep Breath 21:919–927.  https://doi.org/10.1007/s11325-017-1501-x CrossRefPubMedGoogle Scholar
  4. 4.
    Goudis CA, Ketikoglou DG (2017) Obstructive sleep and atrial fibrillation: pathophysiological mechanisms and therapeutic implications. Int J Cardiol 230:293–300.  https://doi.org/10.1016/j.ijcard.2016.12.120 CrossRefPubMedGoogle Scholar
  5. 5.
    Theodoropoulos K, Lykouras D, Karkoulias K, Damania D, Leou K, Lagiou O, Meelu OA, Rigopoulou A, Dangas GD, Hahalis G, Spiropoulos K, Starakis I (2017) Association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease. European Rev Medical Pharmacological Sci 21(7):1568–1575Google Scholar
  6. 6.
    Yuan X, Zhu D, Guo XL, Deng Y, Shang J, Liu K, Liu HG (2015) Telmisartan attenuates myocardial apoptosis induced by chronic intermittent hypoxia in rats: modulation of nitric oxide metabolism and inflammatory mediators. Sleep Breath 19(2):703–709.  https://doi.org/10.1007/s11325-014-1081-y CrossRefPubMedGoogle Scholar
  7. 7.
    Ding W, Zhang X, Huang H, Ding N, Zhang S, Hutchinson SZ, Zhang X (2014) Adiponectin protects rat myocardium against chronic intermittent hypoxia-induced injury via inhibition of endoplasmic reticulum stress. PLoS One 9(4):e94545.  https://doi.org/10.1371/journal.pone.0094545 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Sen N (2017) Functional and molecular insights of hydrogen sulfide signaling and protein sulfhydration. J Mol Biol 429(4):543–561.  https://doi.org/10.1016/j.jmb.2016.12.015 CrossRefPubMedGoogle Scholar
  9. 9.
    Polhemus DJ, Lefer DJ (2014) Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 114(4):730–737.  https://doi.org/10.1161/circresaha.114.300505 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Donnarumma E, Trivedi RK, Lefer DJ (2017) Protective actions of H2S in acute myocardial infarction and heart failure. Comprehensive Physiology 7(2):583–602.  https://doi.org/10.1002/cphy.c160023 CrossRefPubMedGoogle Scholar
  11. 11.
    Burguera EF, Meijide-Failde R, Blanco FJ (2016) Hydrogen sulfide and inflammatory joint diseases. Curr Drug TargetsGoogle Scholar
  12. 12.
    Salloum FN (2015) Hydrogen sulfide and cardioprotection—mechanistic insights and clinical translatability. Pharmacol Ther 152:11–17.  https://doi.org/10.1016/j.pharmthera.2015.04.004 CrossRefPubMedGoogle Scholar
  13. 13.
    Kimura H (2015) Hydrogen sulfide and polysulfides as signaling molecules. Proceedings of the Japan Academy Series B, Physical and biological sciences 91(4):131–159.  https://doi.org/10.2183/pjab.91.131 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Sivarajah A, McDonald MC, Thiemermann C (2006) The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock (Augusta, Ga) 26(2):154–161.  https://doi.org/10.1097/01.shk.0000225722.56681.64 CrossRefGoogle Scholar
  15. 15.
    Polhemus DJ, Calvert JW, Butler J, Lefer DJ (2014) The cardioprotective actions of hydrogen sulfide in acute myocardial infarction and heart failure. Scientifica (Cairo) 2014:768607. doi: https://doi.org/10.1155/2014/768607, 1, 8
  16. 16.
    Lambert JP, Nicholson CK, Amin H, Amin S, Calvert JW (2014) Hydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway. Medical Gas Res 4(1):20.  https://doi.org/10.1186/s13618-014-0020-0 CrossRefGoogle Scholar
  17. 17.
    Polhemus DJ, Kondo K, Bhushan S, Bir SC, Kevil CG, Murohara T, Lefer DJ, Calvert JW (2013) Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis. Circulation Heart Failure 6(5):1077–1086.  https://doi.org/10.1161/circheartfailure.113.000299 CrossRefPubMedGoogle Scholar
  18. 18.
    Li L, Bhatia M, Moore PK (2006) Hydrogen sulphide—a novel mediator of inflammation? Curr Opin Pharmacol 6(2):125–129.  https://doi.org/10.1016/j.coph.2005.10.007 CrossRefPubMedGoogle Scholar
  19. 19.
    Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6(11):917–935.  https://doi.org/10.1038/nrd2425 CrossRefPubMedGoogle Scholar
  20. 20.
    Sun Q, Collins R, Huang S, Holmberg-Schiavone L, Anand GS, Tan CH, van-den-Berg S, Deng LW, Moore PK, Karlberg T, Sivaraman J (2009) Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S. J Biol Chem 284(5):3076–3085.  https://doi.org/10.1074/jbc.M805459200 CrossRefPubMedGoogle Scholar
  21. 21.
    Shirozu K, Tokuda K, Marutani E, Lefer D, Wang R, Ichinose F (2014) Cystathionine gamma-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure. Antioxid Redox Signal 20(2):204–216.  https://doi.org/10.1089/ars.2013.5354 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wesseling S, Fledderus JO, Verhaar MC, Joles JA (2015) Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal. Br J Pharmacol 172(6):1607–1619.  https://doi.org/10.1111/bph.12674 CrossRefPubMedGoogle Scholar
  23. 23.
    Oosterhuis NR, Frenay AR, Wesseling S, Snijder PM, Slaats GG, Yazdani S, Fernandez BO, Feelisch M, Giles RH, Verhaar MC, Joles JA, van Goor H (2015) DL-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats. Nitric Oxide : Biology Chemistry / Official J Nitric Oxide Soc 49:56–66.  https://doi.org/10.1016/j.niox.2015.07.001 CrossRefGoogle Scholar
  24. 24.
    Glembotski CC (2007) Endoplasmic reticulum stress in the heart. Circ Res 101(10):975–984.  https://doi.org/10.1161/circresaha.107.161273 CrossRefPubMedGoogle Scholar
  25. 25.
    Xu J, Zhou Q, Xu W, Cai L (2012) Endoplasmic reticulum stress and diabetic cardiomyopathy. Exp Diabetes Res 2012:827971. doi: https://doi.org/10.1155/2012/827971, 1, 12
  26. 26.
    Lu W, Kang J, Hu K, Tang S, Zhou X, Xu L, Li Y, Yu S (2017) The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia. Sleep Breath 21:667–677.  https://doi.org/10.1007/s11325-016-1449-2 CrossRefPubMedGoogle Scholar
  27. 27.
    Williams AL, Chen L, Scharf SM (2010) Effects of allopurinol on cardiac function and oxidant stress in chronic intermittent hypoxia. Sleep Breath 14(1):51–57.  https://doi.org/10.1007/s11325-009-0279-x CrossRefPubMedGoogle Scholar
  28. 28.
    Wei Q, Bian Y, Yu F, Zhang Q, Zhang G, Li Y, Song S, Ren X, Tong J (2016) Chronic intermittent hypoxia induces cardiac inflammation and dysfunction in a rat obstructive sleep apnea model. J Biomedical Res 30(6):490–495.  https://doi.org/10.7555/jbr.30.20160110 CrossRefGoogle Scholar
  29. 29.
    Chen L, Zhang J, Gan TX, Chen-Izu Y, Hasday JD, Karmazyn M, Balke CW, Scharf SM (2008) Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J Applied Physiology (Bethesda, Md : 1985) 104(1):218–223.  https://doi.org/10.1152/japplphysiol.00301.2007 CrossRefGoogle Scholar
  30. 30.
    Lu D, Liu J, Jiao J, Long B, Li Q, Tan W, Li P (2013) Transcription factor Foxo3a prevents apoptosis by regulating calcium through the apoptosis repressor with caspase recruitment domain. J Biol Chem 288(12):8491–8504.  https://doi.org/10.1074/jbc.M112.442061 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Liu YF, Chu YY, Zhang XZ, Zhang M, Xie FG, Zhou M, Wen HH, Shu AH (2017) TGFbeta1 protects myocardium from apoptosis and oxidative damage after ischemia reperfusion. European Rev Medical Pharmacological Sci 21(7):1551–1558Google Scholar
  32. 32.
    Sun X, Wang W, Dai J, Jin S, Huang J, Guo C, Wang C, Pang L, Wang Y (2017) A long-term and slow-releasing hydrogen sulfide donor protects against myocardial ischemia/reperfusion injury. Sci Rep 7(1):3541.  https://doi.org/10.1038/s41598-017-03941-0 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7(1):35–51CrossRefPubMedGoogle Scholar
  34. 34.
    Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL (2007) Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Phys Heart Circ Phys 293(5):H2971–H2976.  https://doi.org/10.1152/ajpheart.00219.2007 CrossRefGoogle Scholar
  35. 35.
    Edge D, Bradford A, O'Halloran KD (2012) Chronic intermittent hypoxia increases apnoea index in sleeping rats. Adv Exp Med Biol 758:359–363.  https://doi.org/10.1007/978-94-007-4584-1_48 CrossRefPubMedGoogle Scholar
  36. 36.
    Matsumoto C, Hayashi T, Kitada K, Yamashita C, Miyamura M, Mori T, Ukimura A, Ohkita M, Jin D, Takai S, Miyazaki M, Okada Y, Kitaura Y, Matsumura Y (2009) Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice. Hypertension 54(1):164–171.  https://doi.org/10.1161/hypertensionaha.109.131391 CrossRefPubMedGoogle Scholar
  37. 37.
    Inamoto S, Yoshioka T, Yamashita C, Miyamura M, Mori T, Ukimura A, Matsumoto C, Matsumura Y, Kitaura Y, Hayashi T (2010) Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice. Hypertension Res : Official J Japanese Soc Hypertension 33(6):579–586.  https://doi.org/10.1038/hr.2010.36 CrossRefGoogle Scholar
  38. 38.
    Meng G, Wang J, Xiao Y, Bai W, Xie L, Shan L, Moore PK, Ji Y (2015) GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats. J Biomedical Res 29(3):203–213.  https://doi.org/10.7555/jbr.28.20140037 CrossRefGoogle Scholar
  39. 39.
    Nguyen M, Breckenridge DG, Ducret A, Shore GC (2000) Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol Cell Biol 20(18):6731–6740CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Ding W, Yang L, Zhang M, Gu Y (2012) Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells. Biochem Biophys Res Commun 418(3):451–456.  https://doi.org/10.1016/j.bbrc.2012.01.037 CrossRefPubMedGoogle Scholar
  41. 41.
    Bourdier G, Flore P, Sanchez H, Pepin JL, Belaidi E, Arnaud C (2016) High-intensity training reduces intermittent hypoxia-induced ER stress and myocardial infarct size. Am J Phys Heart Circ Phys 310(2):H279–H289.  https://doi.org/10.1152/ajpheart.00448.2015 CrossRefGoogle Scholar
  42. 42.
    Belaidi E, Thomas A, Bourdier G, Moulin S, Lemarie E, Levy P, Pepin JL, Korichneva I, Godin-Ribuot D, Arnaud C (2016) Endoplasmic reticulum stress as a novel inducer of hypoxia inducible factor-1 activity: its role in the susceptibility to myocardial ischemia-reperfusion induced by chronic intermittent hypoxia. Int J Cardiol 210:45–53.  https://doi.org/10.1016/j.ijcard.2016.02.096 CrossRefPubMedGoogle Scholar
  43. 43.
    Bos EM, Wang R, Snijder PM, Boersema M, Damman J, Fu M, Moser J, Hillebrands JL, Ploeg RJ, Yang G, Leuvenink HG, van Goor H (2013) Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrology : JASN 24 (5):759–770. doi: https://doi.org/10.1681/asn.2012030268
  44. 44.
    Guo C, Liang F, Shah Masood W, Yan X (2014) Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-kappaB dependent anti-inflammation pathway. Eur J Pharmacol 725:70–78.  https://doi.org/10.1016/j.ejphar.2014.01.009 CrossRefPubMedGoogle Scholar
  45. 45.
    Jin S, Pu SX, Hou CL, Ma FF, Li N, Li XH, Tan B, Tao BB, Wang MJ, Zhu YC (2015) Cardiac H2S generation is reduced in ageing diabetic mice. Oxidative Med Cell Longev 2015:758358. doi: https://doi.org/10.1155/2015/758358, 1, 14
  46. 46.
    Hosoki R, Matsuki N, Kimura H (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237(3):527–531.  https://doi.org/10.1006/bbrc.1997.6878 CrossRefPubMedGoogle Scholar
  47. 47.
    Zhao W, Zhang J, Lu Y, Wang R (2001) The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20(21):6008–6016.  https://doi.org/10.1093/emboj/20.21.6008 CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Roy A, Khan AH, Islam MT, Prieto MC, Majid DS (2012) Interdependency of cystathione gamma-lyase and cystathione beta-synthase in hydrogen sulfide-induced blood pressure regulation in rats. Am J Hypertens 25(1):74–81.  https://doi.org/10.1038/ajh.2011.149 CrossRefPubMedGoogle Scholar
  49. 49.
    Li L, Hsu A, Moore PK (2009) Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation—a tale of three gases! Pharmacol Ther 123(3):386–400.  https://doi.org/10.1016/j.pharmthera.2009.05.005 CrossRefPubMedGoogle Scholar
  50. 50.
    Jin HF, Du JB, Li XH, Wang YF, Liang YF, Tang CS (2006) Interaction between hydrogen sulfide/cystathionine gamma-lyase and carbon monoxide/heme oxygenase pathways in aortic smooth muscle cells. Acta Pharmacol Sin 27(12):1561–1566.  https://doi.org/10.1111/j.1745-7254.2006.00425.x CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Respiratory DiseaseRenmin Hospital of Wuhan UniversityWuhanChina

Personalised recommendations